Insights
Insights From Our Experts
Articles
A New Era in Point-of-Care Marketing
EVERSANA ENGAGE’s Leana Wood shares insight in PM360 on where she has seen the biggest impact in point of care marketing and the programs that resonate with target audiences. “Point-of-care marketing has a bright and growing…
Ask the Experts: How Does Real World Evidence Ensure Market Access?
Our healthcare system has experienced a fundamental shift in stakeholders’ perceptions of product value and evidentiary thresholds to demonstrate comparative effectiveness, as well as a willingness by relevant decision makers to pay. This value–and–evidence– based landscape…
Increase Your Speed to Market
Commercial Strategies for a Successful Product Launch. With the launch of new blockbuster drugs becoming less frequent, there is increased scrutiny on the importance and success of clinical trials, mandatory to determining the safety and efficacy…
Social Media for Clinical Trial Patient Recruitment: The Comprehensive Guide
A clinical trial is the sole way that new medicines come to market. Mastering the process of finding, engaging, and activating patients for enrollment into a clinical trial is a key success factor for all biopharmaceutical…
Is ICER Increasing Influence in the U.S. Over Time?
Recent high-profile product launches have reignited the debate on healthcare costs in the US. The Institute for Clinical and Economic Review (ICER) is an independent research organization that determines value-based price benchmarks. In a recent study,…
Improving the Impact of an Oncology Patient Access Program
Our client, a specialty pharmaceutical company focused on the research and development of new therapies in two high-cost complex drug categories, sought to benchmark its patient assistance program against those of its competitors in order to…
ICER’s Unsupported Price Increase Assessment
Posted by
Heather Lee Whipple on December 23, 201912/23/19
In October 2019, the Institute of Clinical and Economic Review (ICER) released their first annual report on Unsupported Price Increases of prescription drugs in the United States. The report takes a systematic approach to determine whether…
Trends Disrupting Life Sciences in 2020
From the commercialization of digital medicines to the evolution of value-driven healthcare – our thought leaders deliver insight on the trends impacting the life science industry that will continue to shape our thinking well in 2020…
How to Maximize the Value of New Advances in Oncology
Today we have access to more data, from more sources than we could ever dream possible. Living in a digital world, we increasingly need the ability to efficiently and effectively process this data for insights and…
U.S. physicians disagree with Germany’s determinations of the value of diabetes medicines
According to a recent study from Health Strategies Insights by EVERSANA, 89% of U.S. physicians disagree with Germany’s determinations of the clinical benefit of innovative diabetes medicines. Learn more about our Market Access products & capabilities!…